Select your language


Our experts ensure compliance is a constant

Posted on the 21st September 2023

Warning Letter CMC compliance

Interactions with Health Authorities are key for pharmaceutical companies throughout the world.

However, grasping the ever-changing requisites posed by these bodies can significantly strain the already limited resources of many of these firms.

Non-compliance can result in significant consequences, including severe financial penalties, loss of reputation, unanticipated delays, and even the revocation of licenses.

At G&L Healthcare Advisors, we leverage cutting-edge insights and decades of experience in collaborating with Health Authorities across the globe to ensure that our clients remain compliant and enjoy a journey to market that remains as seamless as possible.

This year alone, multiple manufacturers have faced reprimands from bodies like the U.S. Food and Drug Administration (FDA) due to their failure to adhere to guidelines concerning potential breaches of strict protocols that cover every stage of the product lifecycle.

Though infrequent, such correspondences unmistakably underscore the imperative of upholding complete and consistent compliance with the rigorous regulations established by global Health Authorities.

These regulations can significantly differ across regions, consuming valuable reserves of time and finances.

At G&L, our experts have cultivated unparalleled partnerships with Health Authorities and Agencies worldwide.

Rooted in trust, mutual respect, and a shared goal of enhancing lives, these relationships allow us to navigate the intricate landscape of regulations on behalf of our clients.

To find out how we can support you, click here

Related: Support at every stage of the process

Ready to reach your potential?

Discover how G&L can help you do business better

Contact Us